Welcome to your Weekly Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Voio Emerges From Stealth to Build Frontier AI for Healthcare
Voio, an AI-focused healthcare lab, emerged from stealth with $8.6 million in seed funding from Laude Ventures and The House Fund. The company’s primary goal is to develop a unified reading platform that assists radiologists in interpreting scans across all modalities. Voio is spun out of research labs at the University of California, Berkeley, and the University of California, San Francisco. The founding team has also introduced Pillar-0, an open-source AI model capable of analyzing medical images to detect hundreds of conditions from CT and MRI scans with exceptional accuracy. The initial version of Pillar-0 has demonstrated a 10 to 17 percent improvement in accuracy compared with leading AI models from Google, Microsoft, and Alibaba.
IKS Health Appoints New Chief Marketing and Chief Legal and Compliance Officers
IKS Health, a global leader in care enablement solutions that support clinicians, staff, and patients throughout the care journey, announced the appointment of Kathryn Weismantel as Chief Marketing Officer and Christi Braun as Chief Legal and Compliance Officer.
DarioHealth Study Shows $5,077 Annual Savings Per User
DarioHealth Corp. a leader in global digital health, announced the publication of a new peer-reviewed study in the Journal of Medical Internet Research (JMIR), a highly influential digital health journal, evaluating healthcare utilization and medical costs among Dario users compared to matched non-users receiving usual care. The study, “Effects of a Digital Health Intervention for Adults with Type 2 Diabetes Mellitus on Health Care Resource Use and Health Care Charges in the United States: Retrospective Cohort Study,” was not authored by Dario, but rather conducted by researchers at Sanofi and Symphony Health.
Genesis Lifestyle Medicine Leads the National Movement Toward Modern Wellness
Across the United States, people are raising their expectations for their own well being. They want more energy, better balance, and greater confidence in their daily lives. Genesis Lifestyle Medicine is meeting that demand by reshaping the way modern wellness is delivered. With clinics continuing to open across the country, the company is setting a new standard for medical wellness that is expert directed, results focused, and tailored to each individual.
Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor
Vyome Holdings, Inc. a clinical-stage healthcare holding company, announced Dr. Aditya Bardia as Senior Medical Advisor to Vyome. In this consulting role, Dr. Bardia will guide the clinical development of Vyome’s lead asset, VT-1953, for the treatment of symptoms of malignant fungating wounds (MFW), a debilitating condition in cancer patients for which approval is being targeted in 2026.
Lilly to Showcase HR+ Breast Cancer Advances at SABCS 2025
Eli Lilly and Company, listed on the NYSE as LLY, announced that new data from its breast oncology pipeline and approved medicines will be highlighted at the San Antonio Breast Cancer Symposium, taking place December 9 to 12 in San Antonio, Texas. The updates reflect Lilly’s ongoing progress in addressing hormone receptor-positive, HER2-negative breast cancer, which is the most common type of breast cancer.
FluidAI Medical Announces an Acquisition Deal With Emmetros Limited
FluidAI Medical, a medical technology company that develops novel hardware, software, and artificial intelligence (AI) solutions, announced an acquisition deal with SparxConnect developer Emmetros Limited, a leading company in the patient engagement space. The acquisition enhances Stream Inara, an AI-powered patient education and engagement platform within FluidAI’s product portfolio that extends care beyond the hospital. This is FluidAI’s second acquisition deal after Medsix. Strategic acquisitions remain a core part of FluidAI’s growth strategy, strengthening its position in existing markets and expanding its footprint with established products and technologies.
TOMI Environmental Secures $3 Million Life Sciences Integration Deal
TOMI Environmental Solutions, announces substantial progress in its custom integration pipeline, currently valued at approximately $3 million, signaling significant momentum in the life sciences sector. The company reports ten active projects across its SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms, serving both new and existing customers.
GE Healthcare Launches Pristina Recon DL for Clearer Mammograms
GE HealthCare that it has received FDA Premarket Authorization for Pristina Recon DL, an advanced 3D mammography image reconstruction technology. Powered by deep learning, Pristina Recon DL sets a new standard in image definition and sharpness.
To share your insights, please write to us at sudipto@intentamplify.com
